About: Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases
Creator	Barrett, Alan Saville, Melanie Gilly, John Hepburn, Matthew Mascola, John Blackman, Marcia Kim, Jerome Monath, Thomas Cassetti, M Cummings, James Innis, Bruce Kester, Kent Marchionni, Mark Thomas, Stephen
source	Elsevier; Medline; PMC
abstract	Abstract Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current “gaps,” and prospect what could be done to improve our position. Herein we describe the summit proceedings, “Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases,” held October 2–3, 2018, at the Trudeau Institute in Saranac Lake, NY.
has issue date	2019-10-08(xsd:dateTime)
bibo:doi	10.1016/j.vaccine.2019.08.061
bibo:pmid	31500964
has license	els-covid
sha1sum (hex)	e1c1bc61cdcb0392f1b29b5205e15e4f4ad63fd7
schema:url	https://doi.org/10.1016/j.vaccine.2019.08.061
resource representing a document's title	Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases
has PubMed Central identifier	PMC7131820
has PubMed identifier	31500964
schema:publication	Vaccine
resource representing a document's body	covid:e1c1bc61cdcb0392f1b29b5205e15e4f4ad63fd7#body_text
is schema:about of	named entity 'thought leaders' named entity 'Diseases' named entity 'Viral' named entity 'The' named entity 'Immunology' named entity 'urbanization' named entity 'populations' named entity 'Summit' named entity 'viral diseases' named entity 'BIOMEDICAL' named entity 'PROCEEDINGS' named entity '2018' named entity 'SUMMIT' named entity 'INVENTORY' named entity 'OCTOBER' named entity 'OUTBREAKS' named entity '2-3' named entity 'CHALLENGES' named entity 'PREPARATION' named entity 'COULD BE' named entity 'VECTOR-BORNE' named entity 'DEMONSTRATED' named entity 'POSITION' named entity 'UNIVERSITY' named entity 'ZIKA' named entity 'THREAT' named entity 'BIOMEDICAL' named entity 'PROVEN' named entity 'OPINION' named entity 'ANTI-VACCINATION MOVEMENTS' named entity 'INTERNATIONAL TRAVEL' named entity 'SUPPORTING' named entity 'MEDICAL' named entity 'DEFORESTATION' named entity 'VECTOR-BORNE' named entity 'DEVELOPMENT' named entity 'TO RESPOND' named entity 'RESPONSE' named entity 'THOUGHT' named entity 'EBOLA' named entity 'LAKE' named entity 'EMERGING INFECTIOUS DISEASES' named entity 'THERAPEUTICS' named entity 'COUNTERMEASURE' named entity 'SUMMIT' named entity 'OUR' named entity 'DEVELOPMENT' named entity 'ASSESS' named entity 'MERS-COV' named entity 'URBANIZATION' named entity 'IMMUNOLOGY' named entity 'PUBLIC HEALTH' named entity 'VIRAL DISEASES' named entity 'EXPANDING' named entity 'SECURITY' named entity 'GLOBAL' named entity 'RECENT' named entity 'ECONOMIES' named entity 'KEY' named entity 'DESCRIBE' named entity 'STATE' named entity 'POPULATIONS' named entity 'VACCINES' named entity 'BIOMEDICAL RESEARCH' named entity 'TREND' named entity 'TRUDEAU' named entity 'RELATED' named entity 'COUNTERMEASURE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software